compared with the percutaneous approach, the inability
to use it in patients with calciÔ¨Åed and atherosclerotic
proximal CCA and proximal CCA diameter of less than
6 mm or in patients with less than 5 cm distance from
the clavicle to the carotid bifurcation. Short-term results from the ROADSTER study of high-risk patients
undergoing TCAR with the ENROUTE neuroprotection
and stent system showed